当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 现金流量表

康辰药业

(603590)

  

流通市值:51.05亿  总市值:51.79亿
流通股本:1.59亿   总股本:1.61亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金472,935,522.01233,628,917.31969,690,499.75681,399,880.97
  收到其他与经营活动有关的现金12,472,620.3911,282,483.5722,339,267.0224,619,689.79
  经营活动现金流入小计485,408,142.4244,911,400.88992,029,766.77706,019,570.76
  购买商品、接受劳务支付的现金37,533,739.2610,286,426.0757,070,828.9845,825,704.88
  支付给职工以及为职工支付的现金174,735,799.7898,136,844.51291,533,574.94222,821,457.01
  支付的各项税费54,915,984.3430,128,372.484,954,042.9758,129,441.75
  支付其他与经营活动有关的现金213,663,949.0185,762,793.44442,792,971.79295,343,717.02
  经营活动现金流出小计480,849,472.39224,314,436.42876,351,418.68622,120,320.66
  经营活动产生的现金流量净额4,558,670.0120,596,964.46115,678,348.0983,899,250.1
二、投资活动产生的现金流量:
  收回投资收到的现金611,215,411.05515,215,411.051,191,644,814.091,001,144,814.09
  取得投资收益收到的现金12,894,849.822,617,956.1521,194,350.2512,288,287.34
  处置固定资产、无形资产和其他长期资产收回的现金净额--608,320607,970
  投资活动现金流入小计624,110,260.87517,833,367.21,213,447,484.341,014,041,071.43
  购建固定资产、无形资产和其他长期资产支付的现金26,115,779.318,951,421.6853,449,655.0244,853,149.48
  投资支付的现金612,009,768.72470,009,768.721,115,705,642.33900,500,000
  投资活动现金流出小计638,125,548.03478,961,190.41,169,155,297.35945,353,149.48
  投资活动产生的现金流量净额-14,015,287.1638,872,176.844,292,186.9968,687,921.95
三、筹资活动产生的现金流量:
  取得借款收到的现金122,694,91543,974,915298,867,756.47256,505,696.47
  筹资活动现金流入小计122,694,91543,974,915298,867,756.47256,505,696.47
  偿还债务支付的现金63,017,086.6231,548,768180,456,251.99179,434,554.99
  分配股利、利润或偿付利息支付的现金4,410,913.552,099,068.23102,394,062.77100,432,320.1
  支付其他与筹资活动有关的现金62,000,389.7344,922,189.2133,366,058.1211,339,121.98
  筹资活动现金流出小计129,428,389.978,570,025.44316,216,372.88291,205,997.07
  筹资活动产生的现金流量净额-6,733,474.9-34,595,110.44-17,348,616.41-34,700,300.6
四、汇率变动对现金及现金等价物的影响-136,993.57-84,904.01-26,524.81-1,701.25
五、现金及现金等价物净增加额-16,327,085.6224,789,126.81142,595,393.86117,885,170.2
  加:期初现金及现金等价物余额332,573,095.7332,573,095.7189,977,701.84189,977,701.84
  期末现金及现金等价物余额316,246,010.08357,362,222.51332,573,095.7307,862,872.04
补充资料:
  净利润100,564,729.4-169,423,424.87-
  固定资产和投资性房地产折旧14,392,919.17-23,218,315.68-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,392,919.17-23,218,315.68-
  无形资产摊销4,576,882.92-10,165,790.6-
  长期待摊费用摊销110,048.04-209,165.71-
  处置固定资产、无形资产和其他长期资产的损失--486,253.58-
  固定资产报废损失--86,116.76-
  公允价值变动损失-2,627,457.82--4,176,636.3-
  财务费用4,737,232.75-7,486,033.79-
  投资损失-11,965,245.63--17,697,524-
  递延所得税10,635,493.04-8,146,394.65-
  其中:递延所得税资产减少11,818,802.44-6,335,971.31-
    递延所得税负债增加-1,183,309.4-1,810,423.34-
  存货的减少-1,989,086.19-17,912,759.82-
  经营性应收项目的减少-33,928,312.08--62,363,678.78-
  经营性应付项目的增加-81,499,146.37--63,631,785.3-
  其他-625,753.67-8,982,181.16-
  现金的期末余额316,246,010.08-332,573,095.7-
  减:现金的期初余额332,573,095.7-189,977,701.84-
  现金及现金等价物的净增加额-16,327,085.62-142,595,393.86-
公告日期2026-08-262026-04-232026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑